Table 1.
Patient demographic and clinical information for primary lung cancers (n = 23).
| Age/race/sex | Histology | Stage | Passage* | Differentiation | Smoking |
|---|---|---|---|---|---|
| 72/White/Female | SC | IIB (T2N0M0) | 2 | Moderate | Yes |
| 70/White/Male | SC | IB (T2AN0M0) | 2 | Moderate | Yes |
| 66/White/Female | SC | IB (T2N0M0) | 2 | Moderate | Yes |
| 63/White/Female | SC | IB (T2N0M0) | 2 | Poor | Yes |
| 38/White/Female | SC | IIB (T2BN1M0) | 2 | Moderate | No |
| 53/White/Female | SC | II (T2AN1M0) | 2 | Well | Yes |
| 49/White/Female | SC | IIIA (T3N1M0) | 2 | Poor | Yes |
| 57/African/Male | SC | IIB (T3N0M0) | 4 | Moderate | Yes |
| 63/Caucasia/Male | SC | IIA (T2N1M0) | 4 | Moderate | Yes |
| 54/Caucasia/Male | AC | IIIA(T2N2M0) | 3 | Poor | Yes |
| 58/White/Female | AC | II (T3N0M0) | 2 | Poor | Yes |
| 75/White/Male | AC | II (T2AN0M0) | 3 | Well | Yes |
| 55/Black/Female | AC | IB (T2N0M0) | 3 | Moderate | No |
| 73/White/Female | AC | IB (T2AN0M0) | 1 | Moderate | Yes |
| 55/Hispanic/Male | AC | IIB (T2N0M0) | 3 | Moderate | Yes |
| 62/Black/Female | AC | IB (T2N0M0) | 2 | Well | Yes |
| 68/Hispanic/Male | AC | IIIA(T2AN0M0) | 2 | Moderate | Yes |
| 51/White/Male | AC | IA(T1N0M0) | 2 | Poor | Yes |
| 64/Asian/Male | AC | IB (T2N0M0) | 2 | Moderate | Yes |
| 85/White/Male | AC | IA(T2AN0M0) | 2 | Poor | Yes |
| 54/White/Female | NE | IIIA | 2 | Moderate | Yes |
| 51/Hispanic/Male | Carcinoma/NE | IIIA(T3N1M0) | 3 | Poor | Yes |
| 43/White/Male | Large cell/NE | IIIA(T3N1M0) | 3 | Poor | Yes |
SC, squamous cell carcinoma; AC, adenocarcinoma; NE, neuroendocrine cancer.
*
Passage number indicates PDX passages (F) that were used in sequencing analysis.